Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya

By sjmartinez • May 24, 2023

Wara NJ, Mvududu R, Marwa MM, Gómez L, Mashele N, Orrell C, Moucheraud C, Kinuthia J, John-Stewart G, Myer L, Hoffman R, Pintye J, Davey DLJ. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. J Int AIDS Soc. 2023 May;26(5):e26088. doi: 10.1002/jia2.26088. PMID: 37221983.

Tags: breastfeeding, Infectious Diseases, Kenya, long-acting, pregnancy, PrEP, Publications, south africa

Related Posts

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson[...]

Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle[...]

A New Approach to In Vivo Transformation of Killer T cells

Rodriguez N, Hofmann C, Yang OO, Gelbart WM. A New Approach to In Vivo Transformation of Killer T cells. J Mol Biol. 2025 Aug 1:169369.[...]